FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for CAPTOPRIL from Hikma Pharmaceuticals USA Inc., indicating additional approval for this generic ACE inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)